As a critical oncogenic molecule, miR-145 inhibits the proliferation, invasion, and metastasis of prostate, bladder, and renal cancers while inducing apoptosis in tumor cells by targeting and regulating oncogenic signaling pathways, such as PLD5, SWAP70, and STAT3. Here, PLD5 is linked to renal carcinoma.